Enhanced enzymatic stability and antitumor activity of Daunorubicin-GnRH-III bioconjugates modified in position 4

Lade...
Vorschaubild
Dateien
Zu diesem Dokument gibt es keine Dateien.
Datum
2011
Autor:innen
Orbán, Erika
Baranyai, Zsuzsa
Schulcz, Ákos
Tejeda, Miguel
Kapuvári, Bence
Tóvári, József
Herausgeber:innen
Kontakt
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
DOI (zitierfähiger Link)
ArXiv-ID
Internationale Patentnummer
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Core Facility der Universität Konstanz
Gesperrt bis
Titel in einer weiteren Sprache
Forschungsvorhaben
Organisationseinheiten
Zeitschriftenheft
Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published
Erschienen in
Zusammenfassung

Here, we report on the synthesis, enzymatic stability, and antitumor activity of novel bioconjugates containing the chemotherapeutic agent daunorubicin attached through an oxime bond to various gonadotropin-releasing hormone-III (GnRH-III) derivatives. In order to increase the enzymatic stability of the bioconjugates (in particular against chymotrypsin), 4Ser was replaced by N-Me-Ser or Lys(Ac). A compound in which 4Lys was not acetylated was also prepared, with the aim of investigating the influence of the free ε-amino group on the biochemical properties. The in vitro cytostatic effect of the bioconjugates was determined on MCF-7 human breast, HT-29 human colon, and LNCaP human prostate cancer cells by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Their stability/degradation (1) in human serum, (2) in the presence of rat liver lysosomal homogenate, and (3) in the presence of digestive enzymes (trypsin, chymotrypsin, and pepsin) was analyzed by liquid chromatography in combination with mass spectrometry. The results showed that (1) all synthesized bioconjugates had in vitro cytostatic effect, (2) they were stable in human serum at least for 24 h, and (3) they were hydrolyzed in the presence of lysosomal homogenate. All compounds were stable in the presence of (1) pepsin and (2) trypsin (except for the 4Lys containing bioconjugate). In the presence of chymotrypsin, all bioconjugates were digested; the degradation rate strongly depending on their structure. The bioconjugates in which 4Ser was replaced by N-Me-Ser or Lys(Ac) had the highest enzymatic stability, making them potential candidates for oral administration. In vivo tumor growth inhibitory effect of two selected bioconjugates was evaluated on orthotopically developed C26 murine colon carcinoma bearing mice. The results indicated that the compound containing Lys(Ac) in position 4 had significantly higher antitumor activity than the parent bioconjugate.

Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
540 Chemie
Schlagwörter
Konferenz
Rezension
undefined / . - undefined, undefined
Zitieren
ISO 690MANEA, Marilena, Ulrike LEURS, Erika ORBÁN, Zsuzsa BARANYAI, Peter ÖHLSCHLÄGER, Andreas MARQUARDT, Ákos SCHULCZ, Miguel TEJEDA, Bence KAPUVÁRI, József TÓVÁRI, Gábor MEZŐ, 2011. Enhanced enzymatic stability and antitumor activity of Daunorubicin-GnRH-III bioconjugates modified in position 4. In: Bioconjugate Chemistry. 2011, 22(7), pp. 1320-1329. ISSN 1043-1802. eISSN 1520-4812. Available under: doi: 10.1021/bc100547p
BibTex
@article{Manea2011Enhan-17242,
  year={2011},
  doi={10.1021/bc100547p},
  title={Enhanced enzymatic stability and antitumor activity of Daunorubicin-GnRH-III bioconjugates modified in position 4},
  number={7},
  volume={22},
  issn={1043-1802},
  journal={Bioconjugate Chemistry},
  pages={1320--1329},
  author={Manea, Marilena and Leurs, Ulrike and Orbán, Erika and Baranyai, Zsuzsa and Öhlschläger, Peter and Marquardt, Andreas and Schulcz, Ákos and Tejeda, Miguel and Kapuvári, Bence and Tóvári, József and Mező, Gábor}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/17242">
    <dc:creator>Kapuvári, Bence</dc:creator>
    <dc:contributor>Schulcz, Ákos</dc:contributor>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dcterms:issued>2011</dcterms:issued>
    <dc:creator>Baranyai, Zsuzsa</dc:creator>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:creator>Tóvári, József</dc:creator>
    <dc:creator>Schulcz, Ákos</dc:creator>
    <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/17242"/>
    <dc:creator>Manea, Marilena</dc:creator>
    <dc:contributor>Öhlschläger, Peter</dc:contributor>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-11-30T16:06:08Z</dcterms:available>
    <dc:contributor>Kapuvári, Bence</dc:contributor>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/52"/>
    <dc:contributor>Leurs, Ulrike</dc:contributor>
    <dc:creator>Marquardt, Andreas</dc:creator>
    <dc:rights>terms-of-use</dc:rights>
    <dc:creator>Öhlschläger, Peter</dc:creator>
    <dc:creator>Tejeda, Miguel</dc:creator>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/29"/>
    <dcterms:title>Enhanced enzymatic stability and antitumor activity of Daunorubicin-GnRH-III bioconjugates modified in position 4</dcterms:title>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-11-30T16:06:08Z</dc:date>
    <dc:creator>Mező, Gábor</dc:creator>
    <dc:contributor>Tóvári, József</dc:contributor>
    <dc:language>eng</dc:language>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:contributor>Orbán, Erika</dc:contributor>
    <dc:creator>Leurs, Ulrike</dc:creator>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/29"/>
    <dc:contributor>Marquardt, Andreas</dc:contributor>
    <dcterms:bibliographicCitation>Publ. in: Bioconjugate Chemistry ; 22 (2011), 7. - S. 1320–1329</dcterms:bibliographicCitation>
    <dcterms:abstract xml:lang="eng">Here, we report on the synthesis, enzymatic stability, and antitumor activity of novel bioconjugates containing the chemotherapeutic agent daunorubicin attached through an oxime bond to various gonadotropin-releasing hormone-III (GnRH-III) derivatives. In order to increase the enzymatic stability of the bioconjugates (in particular against chymotrypsin), 4Ser was replaced by N-Me-Ser or Lys(Ac). A compound in which 4Lys was not acetylated was also prepared, with the aim of investigating the influence of the free ε-amino group on the biochemical properties. The in vitro cytostatic effect of the bioconjugates was determined on MCF-7 human breast, HT-29 human colon, and LNCaP human prostate cancer cells by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Their stability/degradation (1) in human serum, (2) in the presence of rat liver lysosomal homogenate, and (3) in the presence of digestive enzymes (trypsin, chymotrypsin, and pepsin) was analyzed by liquid chromatography in combination with mass spectrometry. The results showed that (1) all synthesized bioconjugates had in vitro cytostatic effect, (2) they were stable in human serum at least for 24 h, and (3) they were hydrolyzed in the presence of lysosomal homogenate. All compounds were stable in the presence of (1) pepsin and (2) trypsin (except for the 4Lys containing bioconjugate). In the presence of chymotrypsin, all bioconjugates were digested; the degradation rate strongly depending on their structure. The bioconjugates in which 4Ser was replaced by N-Me-Ser or Lys(Ac) had the highest enzymatic stability, making them potential candidates for oral administration. In vivo tumor growth inhibitory effect of two selected bioconjugates was evaluated on orthotopically developed C26 murine colon carcinoma bearing mice. The results indicated that the compound containing Lys(Ac) in position 4 had significantly higher antitumor activity than the parent bioconjugate.</dcterms:abstract>
    <dc:creator>Orbán, Erika</dc:creator>
    <dc:contributor>Manea, Marilena</dc:contributor>
    <dc:contributor>Tejeda, Miguel</dc:contributor>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/52"/>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:contributor>Mező, Gábor</dc:contributor>
    <dc:contributor>Baranyai, Zsuzsa</dc:contributor>
  </rdf:Description>
</rdf:RDF>
Interner Vermerk
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Kontakt
URL der Originalveröffentl.
Prüfdatum der URL
Prüfungsdatum der Dissertation
Finanzierungsart
Kommentar zur Publikation
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Ja
Begutachtet
Diese Publikation teilen